Citi: "Biosecurity Law" Uncertainty Affects Investor Confidence in the CXO Sector

智通財經
2024.09.10 07:15
花旗發表報告指，美眾院通過《生物安全法案》，目前未清楚美參議院會否採用眾議院版本的《生物安全法案》或另一個版本，或對《生物安全法案》附加更大法案。該行相信藥明康德和藥明生物股價被低估，惟指不確定性影響投資者對 CXO 板塊信心。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.